Last Updated on December 24, 2023 by The Health Master
Alembic Pharmaceuticals Limited‘s wholly owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for lidocaine and prilocaine cream USP, 2.5%/2.5%.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Emla cream, 2.5%/2.5%, of Teva Branded Pharmaceutical Products R&D, Inc.
Lidocaine 2.5% and prilocaine 2.5% cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anaesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery.
And as pre-treatment for infiltration anaesthesia. Lidocaine 2.5% and prilocaine 2.5% cream is not recommended in any clinical situation when penetration or migration beyond the tympanic membrane into the middle ear is possible because of the ototoxic effects observed in animal studies.
Lidocaine and prilocaine cream USP, 2.5%/2.5% has an estimated market size of US$ 29 million for twelve months ending December 2021 according to IQVIA. Alembic has received a cumulative total of 163 ANDA approvals (140 final approvals and 23 tentative approvals) from USFDA.
USFDA gives nod to Indoco Remedies for Lacosamide injection
USFDA gives tentative approval to Alembic for generic Pradaxa capsules
USFDA approves Cell Therapy for earlier lymphoma
USFDA approves Ozempic 2 mg to treat Type-II Diabetes
USFDA gives nod to Lupin for Sildenafil for oral suspension
USFDA gives approval to Glenmark Pharma for Lacosamide Tablets
Moderna recalls thousands of C-19 vaccine doses
USFDA gives Zero Observations to SMS Lifesciences
NPPA fixes ceiling price of these two vaccines
Online दवा बिक्री पर रोक लगाए सरकार, CAIT ने लगाई मंत्रियों से गुहार: Must read
After Cosmetics and Blood, now scientists detect microplastics in Lungs
CDSCO gives nod to Mylan to import and market Liposomal Amphotericin…
Indian Ophthalmic Manufacturers stress on importance of USFDA norms
42% of samples detected with prima facie violation of DPCO: Govt
USFDA gives nod to Indoco Remedies for Lacosamide injection
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
